MedTech News
.................... by Andrew Celentano
First single-cell DNA analysis reveals mitochondrial damage in vulnerable Parkinson’s brainstem neurons
Researchers have carried out the first single-cell analysis of mitochondrial DNA in a population of brainstem neurons that are particularly vulnerable to degeneration in Parkinson’s disease.
Key driver of aggressive prostate cancer identified, suggesting new way to reverse drug resistance
Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine whether prostate tumors remain sensitive to treatment or evolve into a more aggressive, drug-resistant form of the disease.
Cambridge Heartwear Awarded £184 Million NHS Tender for World’s First Medical-Grade, Wirelessly Charged, Reusable ECG Wearable
CAMBRIDGE, England, Oct. 6, 2026 /PRNewswire/ — Cambridge Heartwear® Limited (www.camheartwear.com) has secured a landmark £184 million tender with the National Health Service (NHS) of the UK for HeartSense®, the world’s first medical-grade, multi-channel, portable, wirelessly charged ECG wearable straight to one’s mobile phone, representing a significant advancement in global Medical technology, AI application and cardiovascular diagnostics.
icotec Receives CMS approval for New Technology Add-On Payment for its CMORE® CT System
ALTSTÄTTEN, Switzerland and BOSTON, Oct. 6, 2026 /PRNewswire/ — icotec, the global leader in radiolucent implants for spine tumors and other complex spinal surgery patients, today announced that the Centers for Medicare & Medicaid Services (CMS) has approved a New Technology Add-On Payment (NTAP) for icotec’s spine implant system, CMORE® CT, effective October 1, 2026.
Happy Health’s ring secures FDA clearance for blood pressure measurement
Happy Health’s Happy Ring previously secured FDA approval for its use in the diagnosis and monitoring of sleep apnoea.
Aevice Health gains FDA clearance for AI-powered wheeze detection software
The Class II decision-support software analyses lung sound recordings from compatible FDA-cleared electronic stethoscopes and flags recordings suggestive of wheeze for clinical review.
AIRS Medical Receives FDA Clearance for SwiftSight Body Composition
SwiftSight Body Composition is designed around a scan of less than five minutes, followed by automated AI analysis
Cell-free treatment reduces brain damage and improves recovery after stroke in mice
Ischemic stroke can leave lasting neurological damage after the initial vascular event, with oxidative stress, neuroinflammation, neuronal death and disruption of neural connectivity contributing to impaired recovery. Although current interventions provide partial protection, their ability to prevent delayed neuronal injury remains limited, highlighting a major barrier to functional recovery.